E. A. Antonova

ORCID: 0000-0003-4580-0020
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Tryptophan and brain disorders
  • SARS-CoV-2 and COVID-19 Research
  • Immunodeficiency and Autoimmune Disorders
  • Pediatric health and respiratory diseases
  • Chronic Lymphocytic Leukemia Research
  • Herbal Medicine Research Studies
  • Sarcoidosis and Beryllium Toxicity Research
  • Tuberculosis Research and Epidemiology
  • Immune Response and Inflammation
  • Human Health and Disease
  • Immune responses and vaccinations
  • Medical and Biological Ozone Research
  • Inflammasome and immune disorders
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Child and Adolescent Health
  • Dermatological and COVID-19 studies
  • Cancer Immunotherapy and Biomarkers
  • Iron Metabolism and Disorders
  • Toxin Mechanisms and Immunotoxins

City Hospital № 1 named after. ON. Semashko
2021-2023

Rostov State Medical University
2015-2023

Ministry of Health of the Russian Federation
2019

Pirogov Russian National Research Medical University
2019

Clinical Hospital No. 8
2010

Currently in clinical practice widely used drugs local antimicrobial such as Tantum Verde (benzydamine) Rosa Miramistin (benzyldimethyl-miristoilamino-propylammonium) Hexoral (hexetidin), chlorhexidine (chlorhexidine), Septolete total (benzydamine + cetylpyridinium chloride). The mechanism of action these very similar. We evaluated the effect on viability lymphoid tissue cells and their neutrophilic part immune system, which are most important factors immunity and, at same time, system is...

10.21518/2079-701x-2019-8-76-82 article EN cc-by-nc-nd Meditsinskiy sovet = Medical Council 2019-04-18

Клиническая иммунология

10.33029/0206-4952-2021-42-4-518-525 article RU Immunologiya 2021-01-01

Objective: to study the clinical and immunological parameters of patients with COVID-19 in moderate form varying degrees lung tissue damage. Materials methods: 80 hospitalized a diagnosis «COVID-19, form; complication: bilateral polysegmental interstitial pneumonia» were examined. The difference laboratory (general clinical, biochemical immunological) was evaluated depending on degree damage (up 25 up 50%). Comparison group: 20 healthy volunteers. Results: differences between different...

10.21886/2219-8075-2023-14-4-22-28 article EN cc-by Medical Herald of the South of Russia 2023-11-20

COVID-19 is known to have two main clinical periods: active viral replication followed by immune dysregulation or hyperinflammatory response. Therefore, early initiation of antiviral therapy that limits and prevents lifethreatening complication appears be rational. Ingavirin® one well-known drugs proved effective against a wide range respiratory viruses in adults children. The efficacy the highly pathogenic SARS-CoV was demonstrated preclinical studies even before pandemic. Thus, developed...

10.20953/1729-9225-2022-2-6-15 article EN Infekcionnye bolezni 2022-01-01

The results of cytokines serum levels in patients with infectious and autoimmune phenotypes X-linked agammaglobulinemia (X-AGG) common variable immunodeficiency (CVID) are presented. In varying nature the primary similar cytokine changes were estimated.

10.36691/rja476 article EN cc-by-nc-nd Russian Journal of Allergy 2015-12-15

Objective : To study the features of immune status in patients with a moderate-to-severe course COVID-19, depending levels blood lactate dehydrogenase. Materials and Methods: A total 24 form COVID-19 were examined. The control group consisted 21 healthy volunteers. clinical, paraclinical (computed tomography lungs; complete count, biochemistry; immunological studies), statistical. Results Changes count biochemistry consist granulocytosis, lymphopenia, monocytopenia, an increase level...

10.21886/2219-8075-2021-12-4-108-115 article EN cc-by Medical Herald of the South of Russia 2021-11-09

The short literature review of the problem anemia and lung lesions as a systemic manifestations rheumatoid arthritis (RA) are presented. chronic disease occurs in RA patients most frequently, mechanisms its development description variants is performed. There patient case report, has suffered from with such main clinical interstitial pneumonia.

10.17816/clinpract1426-30 article EN cc-by-nc-nd Journal of clinical practice 2010-12-15

Data of morbidity respiratory diseases in children at Sankt-Petersburg are given the article. The authors described significance and current features children, showed a role mucostasis poor course importance mucoactive therapy community-acquired in-hospital pathologies. Results post-marketing clinical trial efficacy Prospan 180 6 months to 17 years age with wide-spread have been presented High mucolytic bronchodilating activity good safety profile Prospan, which is dry extract ivy leaves,...

10.18093/0869-0189-2008-0-4-86-92 article EN PULMONOLOGIYA 2008-08-28

Cystic fibrosis is a hereditary disease that affects the quality of life patients without proper treatment. It has been established allergic diseases have become global public health problem. Due to variety clinical manifestations affect development, and life, it difficult diagnose. high incidence problems, there problem interrelationship genetic - cystic spectral sensitization children suffering from morbidity in order improve algorithms, condition patients, due appointment diet therapy.

10.31146/1682-8658-ecg-171-11-89-92 article EN cc-by Experimental and Clinical Gastroenterology 2019-11-20
Coming Soon ...